Sandman L - Search Results

1

Quality assurance in a large clinical trials consortium: the experience of the Tuberculosis Trials Consortium.

Sandman L, Mosher A, Khan A, Tapy J, Condos R, Ferrell S, Vernon A; Tuberculosis Trials Consortium. Sandman L, et al. Contemp Clin Trials. 2006 Dec;27(6):554-60. doi: 10.1016/j.cct.2006.06.003. Epub 2006 Jul 28. Contemp Clin Trials. 2006. PMID: 16876488

2

Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22).

Conwell DS, Mosher A, Khan A, Tapy J, Sandman L, Vernon A, Horsburgh CR Jr. Conwell DS, et al. Among authors: sandman l. Contemp Clin Trials. 2007 May;28(3):288-94. doi: 10.1016/j.cct.2006.09.003. Epub 2006 Sep 28. Contemp Clin Trials. 2007. PMID: 17107825

3

Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.

Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA; Tuberculosis Trials Consortium. Benator DA, et al. Among authors: sandman l. Pharmacotherapy. 2007 Jun;27(6):793-800. doi: 10.1592/phco.27.6.793. Pharmacotherapy. 2007. PMID: 17542762 Clinical Trial.

4

DNA fingerprints from Mycobacterium tuberculosis isolates of patients confined for therapy noncompliance show frequent clustering.

O'Brien JK, Sandman LA, Kreiswirth BN, Rom WN, Schluger NW. O'Brien JK, et al. Among authors: sandman la. Chest. 1997 Aug;112(2):387-92. doi: 10.1378/chest.112.2.387. Chest. 1997. PMID: 9266873 Free article.

5

Risk factors for rifampin-monoresistant tuberculosis: A case-control study.

Sandman L, Schluger NW, Davidow AL, Bonk S. Sandman L, et al. Am J Respir Crit Care Med. 1999 Feb;159(2):468-72. doi: 10.1164/ajrccm.159.2.9805097. Am J Respir Crit Care Med. 1999. PMID: 9927359 Clinical Trial.

6

Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.

Davidson M, Krugman S, Sandman LA. Davidson M, et al. Among authors: sandman la. Vaccine. 1992;10 Suppl 1:S119-20. doi: 10.1016/0264-410x(92)90562-x. Vaccine. 1992. PMID: 1335639 Clinical Trial.

7

Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.

Sandman L, Davidson M, Krugman S. Sandman L, et al. J Infect Dis. 1995 Mar;171 Suppl 1:S50-2. doi: 10.1093/infdis/171.supplement_1.s50. J Infect Dis. 1995. PMID: 7876649 Clinical Trial.

8

Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.

Clements ML, Miskovsky E, Davidson M, Cupps T, Kumwenda N, Sandman LA, West D, Hesley T, Ioli V, Miller W, et al. Clements ML, et al. Among authors: sandman la. J Infect Dis. 1994 Sep;170(3):510-6. doi: 10.1093/infdis/170.3.510. J Infect Dis. 1994. PMID: 8077707 Clinical Trial.

9

The costs per live birth after uterus transplantation: results of the Swedish live donor trial.

Brännström M, Ekberg J, Sandman L, Davidson T. Brännström M, et al. Among authors: sandman l. Hum Reprod. 2024 Dec 15:deae272. doi: 10.1093/humrep/deae272. Online ahead of print. Hum Reprod. 2024. PMID: 39675045

10

Severity and Temporality in Healthcare Priority Setting - A Case for A Condition-specific Affectable Time-neutral Approach.

Sandman L, Juth N. Sandman L, et al. Health Care Anal. 2024 Oct 24. doi: 10.1007/s10728-024-00493-z. Online ahead of print. Health Care Anal. 2024. PMID: 39446253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters